ClearBridge Investments’s Abiomed Inc ABMD Stock Holding History

ClearBridge Investments’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-41	Closed	-$7K	–	1157
2019 Q3	$7K	Buy	+41	New	+$8.86K	﹤0.01%	1016

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments's ABMD Position: Q4 2019 in Review

ClearBridge Investments sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 41 shares — an estimated $7K sold.

ClearBridge Investments first reported a position in ABMD in Q3 2019 and held it in 1 quarter. The position peaked at $7K in Q3 2019. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

ClearBridge Investments reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
ClearBridge Investments sold 41 Abiomed Inc shares in Q4 2019, an estimated $7K.
ClearBridge Investments first reported a position in Abiomed Inc in Q3 2019 and held it in 1 quarter.
ClearBridge Investments's Abiomed Inc position peaked at $7K in Q3 2019.
465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on ClearBridge Investments's 13F filing for Q4 2019, filed 14 Feb 2020.